Activation of P53 by Scaffold-stabilised Expression of Mdm2-binding Peptides: Visualisation of Reporter Gene Induction at the Single-cell Level
Overview
Affiliations
Small peptides that perturb intracellular signalling pathways are useful tools in the identification and validation of new drug targets. To facilitate the analysis of biologically active peptides, we have developed retroviral vectors expressing an intracellular scaffold protein that significantly enhances the stability of small peptides in mammalian cells. This approach was chosen because retroviral transduction results in efficient and controlled delivery of the gene encoding the effector peptide, while the scaffold protein not only stabilises the peptide but also facilitates the analysis and potential isolation of the target protein. Here, we have adapted a p53-responsive reporter assay to flow cytometry to demonstrate the versatility of this approach by using peptides with known Mdm2-binding activities inserted into a stable scaffold protein that is suitable for intracellular expression in multiple compartments of mammalian cells. This strategy should be generally applicable to the study of small biologically active peptides in diverse functional assays.
High-throughput protein binder discovery by rapid in vivo selection.
Styles M, Pixley J, Wei T, Basile C, Basile C, Lu S bioRxiv. 2025; .
PMID: 39829796 PMC: 11741316. DOI: 10.1101/2025.01.06.631531.
Rapid recruitment of p53 to DNA damage sites directs DNA repair choice and integrity.
Wang Y, Ho T, Hariharan A, Goh H, Liang Wong Y, Verkaik N Proc Natl Acad Sci U S A. 2022; 119(10):e2113233119.
PMID: 35235448 PMC: 8915893. DOI: 10.1073/pnas.2113233119.
Awakening guardian angels: drugging the p53 pathway.
Brown C, Lain S, Verma C, Fersht A, Lane D Nat Rev Cancer. 2009; 9(12):862-73.
PMID: 19935675 DOI: 10.1038/nrc2763.